FDA Approves First Pill To Extend Survival In Advanced Pancreatic Cancer

THURSDAY, Aug. 27, 2026— The U.S. Food and Drug Administration (FDA) has approved the first drug shown to substantially extend the lives of people with advanced pancreatic cancer, nearly doubling survival time in a key clinical trial.The pill...